癌症治疗相关的心血管毒性仍然是一个主要的临床挑战，色瑞替尼是一种间变性淋巴瘤激酶（ALK）抑制剂，与心血管不良事件相关，但其机制尚未完全阐明。近期浙江大学智能创新药物研究院徐志飞研究员团队在Acta Pharmacologica Sinica(IF ...
60 yıllık longevity araştırmasının vardığı son nokta şu: Vücuttaki gençlik molekülü NAD’ı tüketen zombi hücreleri durdurmanın ...
HighTide reports preclinical findings showing HTD1801 reduced cyst expansion in human nephron organoids modelling autosomal ...
In Vorstudien an Tiermodellen sowie in kleineren Pilotstudien am Menschen zeigte DHB stärkere Effekte auf die ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results